Page 165 - Read Online

respectively. This work was supported by a PhD thesis 19. Hu JH, Zheng XY, Yang JP, Wang LN, Ji FH. Involvement of spinal
scholarship to Line Pourtau from la Ligue contre le Cancer monocyte chemoattractant protein‑1 (MCP‑1) in cancer‑induced
bone pain in rats. Neurosci Lett 2012;517:60‑3.
and by a Master scholarship to Amarins Nieske Heeringa 20. Pevida M, González‑Rodríguez S, Lastra A, Hidalgo A, Menéndez
from KWF Kanker Bestrijding. L, Baamonde A. CCL2 released at tumoral level contributes to the
hyperalgesia evoked by intratibial inoculation of NCTC 2472 but
REFERENCES not B16‑F10 cells in mice. Naunyn Schmiedebergs Arch Pharmacol
2012;385:1053‑61.
1. Coleman RE. Skeletal complications of malignancy. Cancer 21. Pevida M, González‑Rodríguez S, Lastra A, García‑Suárez O,
1997;80:1588‑94. Hidalgo A, Menéndez L, Baamonde A. Involvement of spinal
2. Rubens RD. Bone metastases ‑ the clinical problem. Eur J Cancer chemokine CCL2 in the hyperalgesia evoked by bone cancer
1998;34:210‑3. in mice: a role for astroglia and microglia. Cell Mol Neurobiol
3. Lee DM, Weinblatt ME. Rheumatoid arthritis. Lancet 2014;34:143‑56.
2001;358:903‑11. 22. Abram SE, Yi J, Fuchs A, Hogan QH. Permeability of injured and
4. Creamer P, Lethbridge‑Cejku M, Hochberg MC. Where does it hurt? intact peripheral nerves and dorsal root ganglia. Anesthesiology
Pain localization in osteoarthritis of the knee. Osteoarthritis Cartilage 2006;105:146‑53.
1998;6:318‑23. 23. Gardiner NJ, Cafferty WB, Slack SE, Thompson SW. Expression
5. van Baar ME, Dekker J, Oostendorp RA, Bijl D, Voorn TB, of gp130 and leukaemia inhibitory factor receptor subunits in adult
Lemmens JA, Lemmens JA, Bijlsma JW. The effectiveness of rat sensory neurones: regulation by nerve injury. J Neurochem
exercise therapy in patients with osteoarthritis of the hip or knee: a 2002;83:100‑9.
randomized clinical trial. J Rheumatol 1998;25:2432‑9. 24. Andratsch M, Mair N, Constantin CE, Scherbakov N, Benetti C,
6. Delaney A, Fleetwood‑Walker SM, Colvin LA, Fallon M. Translational Quarta S, Vogl C, Sailer CA, Uceyler N, Brockhaus J, Martini R,
medicine: cancer pain mechanisms and management. Br J Anaesth Sommer C, Zeilhofer HU, Muller W, Kuner R, Davis JB, Rose‑John S,
2008;101:87‑94. Kress M. A key role for gp130 expressed on peripheral sensory nerves
7. Ji RR, Xu ZZ, Gao YJ. Emerging targets in neuroinflammation‑driven in pathological pain. J Neurosci 2009;29:13473‑83.
chronic pain. Nat Rev Drug Discov 2014;13:533‑48. 25. Sweitzer SM, Colburn RW, Rutkowski M, DeLeo JA. Acute peripheral
8. Ferreira SH, Lorenzetti BB, Bristow AF, Poole S. Interleukin‑1 beta inflammation induces moderate glial activation and spinal IL‑1beta
as a potent hyperalgesic agent antagonized by a tripeptide analogue. expression that correlates with pain behavior in the rat. Brain Res
Nature 1988;334:698‑700. 1999;829:209‑21.
9. Watkins LR, Goehler LE, Relton J, Brewer MT, Maier SF. Mechanisms 26. Bao L, Zhu Y, Elhassan AM, Wu Q, Xiao B, Zhu J, Lindgren JU.
of tumor necrosis factor‑alpha (TNF‑alpha) hyperalgesia. Brain Res Adjuvant‑induced arthritis: IL‑1 beta, IL‑6 and TNF‑alpha are
1995;692:244‑50. up‑regulated in the spinal cord. Neuroreport 2001;12:3905‑8.
10. Reeve AJ, Patel S, Fox A, Walker K, Urban L. Intrathecally 27. Raghavendra V, Tanga FY, DeLeo JA. Complete Freunds
administered endotoxin or cytokines produce allodynia, hyperalgesia adjuvant‑induced peripheral inflammation evokes glial activation
and changes in spinal cord neuronal responses to nociceptive stimuli and proinflammatory cytokine expression in the CNS. Eur J Neurosci
in the rat. Eur J Pain 2000;4:247‑57. 2004;20:467‑73.
11. Sung CS, Wen ZH, Chang WK, Ho ST, Tsai SK, Chang YC, 28. Mao‑Ying QL, Wang XW, Yang CJ, Li X, Mi WL, Wu GC, Wang YQ.
Wong CS. Intrathecal interleukin‑1beta administration induces Robust spinal neuroinflammation mediates mechanical allodynia in
thermal hyperalgesia by activating inducible nitric oxide synthase Walker 256 induced bone cancer rats. Mol Brain 2012;5:16.
expression in the rat spinal cord. Brain Res 2004;1015:145‑53. 29. Rabchevsky AG, Degos JD, Dreyfus PA. Peripheral injections of
12. Kwon MS, Shim EJ, Seo YJ, Choi SS, Lee JY, Lee HK, Suh HW. Freund’s adjuvant in mice provoke leakage of serum proteins
Differential modulatory effects of cholera toxin and pertussis through the blood‑brain barrier without inducing reactive gliosis.
toxin on pain behavior induced by TNF‑alpha, interleukin‑1beta Brain Res 1999;832:84‑96.
and interferon‑gamma injected intrathecally. Arch Pharm Res 30. Honore P, Rogers SD, Schwei MJ, Salak‑Johnson JL, Luger NM,
2005;28:582‑6. Sabino MC, Clohisy DR, Mantyh PW. Murine models of
13. Qin X, Wan Y, Wang X. CCL2 and CXCL1 trigger calcitonin inflammatory, neuropathic and cancer pain each generates a
gene‑related peptide release by exciting primary nociceptive unique set of neurochemical changes in the spinal cord and sensory
neurons. J Neurosci Res 2005;82:51‑62. neurons. Neuroscience 2000;98:585‑98.
14. Dansereau MA, Gosselin RD, Pohl M, Pommier B, Mechighel P, 31. Sabino MA, Luger NM, Mach DB, Rogers SD, Schwei MJ,
Mauborgne A, Rostene W, Kitabgi P, Beaudet N, Sarret P, Mantyh PW. Different tumors in bone each give rise to a distinct
Melik‑Parsadaniantz S. Spinal CCL2 pronociceptive action is pattern of skeletal destruction, bone cancer‑related pain behaviors
no longer effective in CCR2 receptor antagonist‑treated rats. and neurochemical changes in the central nervous system. Int J
J Neurochem 2008;106:757‑69. Cancer 2003;104:550‑8.
15. Woolf CJ, Allchorne A, Safieh‑Garabedian B, Poole S. Cytokines, 32. Ducourneau VR, Dolique T, Hachem‑Delaunay S, Miraucourt LS,
nerve growth factor and inflammatory hyperalgesia: the contribution Amadio A, Blaszczyk L, Jacquot F, Ly J, Devoize L, Oliet SH,
of tumour necrosis factor alpha. Br J Pharmacol 1997;121:417‑24. Dallel R, Mothet JP, Nagy F, Fenelon VS, Voisin DL. Cancer pain
16. Baamonde A, Curto‑Reyes V, Juárez L, Meana A, Hidalgo A, is not necessarily correlated with spinal overexpression of reactive
Menéndez L. Antihyperalgesic effects induced by the IL‑1 receptor glia markers. Pain 2014;155:275‑91.
antagonist anakinra and increased IL‑1beta levels in inflamed and 33. Schwei MJ, Honore P, Rogers SD, Salak‑Johnson JL, Finke MP,
osteosarcoma‑bearing mice. Life Sci 2007;81:673‑82. Ramnaraine ML, Clohisy DR, Mantyh PW. Neurochemical and
17. Constantin CE, Mair N, Sailer CA, Andratsch M, Xu ZZ, Blumer MJ, cellular reorganization of the spinal cord in a murine model of bone
Scherbakov N, Davis JB, Bluethmann H, Ji RR, Kress M. cancer pain. J Neurosci 1999;19:10886‑97.
Endogenous tumor necrosis factor alpha (TNFalpha) requires TNF 34. Pedersen LM, Jacobsen LM, Mollerup S, Gjerstad J. Spinal cord
receptor type 2 to generate heat hyperalgesia in a mouse cancer long‑term potentiation (LTP) is associated with increased dorsal
model. J Neurosci 2008;28:5072‑81. horn gene expression of IL‑1beta, GDNF and iNOS. Eur J Pain
18. Zhang RX, Li A, Liu B, Wang L, Ren K, Zhang H, Berman BM, Lao L. 2010;14:255‑60.
IL‑1ra alleviates inflammatory hyperalgesia through preventing 35. Gauldie SD, McQueen DS, Clarke CJ, Chessell IP. A robust model
phosphorylation of NMDA receptor NR‑1 subunit in rats. Pain of adjuvant‑induced chronic unilateral arthritis in two mouse strains.
2008;135:232‑9. J Neurosci Methods 2004;139:281‑91.

Neuroimmunol Neuroinflammation | Volume 1 | Issue 3 | December 2014 159